Last reviewed · How we verify
AGEE cream
AGEE cream, developed by the University of Nebraska, is a marketed topical treatment with a key composition patent expiring in 2028. The drug's primary strength lies in its unique mechanism of action, which differentiates it from existing treatments. The primary risk is the potential for increased competition once the key patent expires in 2028.
At a glance
| Generic name | AGEE cream |
|---|---|
| Also known as | creatine ethyl ester based topical |
| Sponsor | University of Nebraska |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |